He; John Xiaoqiang
Patent Applications and Registrations
Patent applications and USPTO patent grants for He; John Xiaoqiang.The latest application filed is for "substituted piperazines of azepines, oxazepines and thiazepines".
- He; John Xiaoqiang - Fishers IN
- He; John Xiaoqiang - Indianapolis IN
- He; John Xiaoqiang - Ypsilanti MI
| Patent | Date |
|---|---|
| .beta.3 adrenergic agonists Grant 7,208,505 - Sall , et al. April 24, 2 | 2007-04-24 |
| Indole derivatives for the treatment of depression and anxiety Grant 7,144,898 - Hansen , et al. December 5, 2 | 2006-12-05 |
| Substituted piperazines of azepines, oxazepines and thiazepines App 20060270656 - He; John Xiaoqiang ; et al. | 2006-11-30 |
| 3-substituted oxindole .beta.3 agonists Grant 7,087,635 - Sall , et al. August 8, 2 | 2006-08-08 |
| 3-Substituted oxindole beta3 agonists App 20050159473 - Sall, Daniel Jon ; et al. | 2005-07-21 |
| 3-substituted oxindole .beta.-3 agonists Grant 6,911,463 - Sall , et al. June 28, 2 | 2005-06-28 |
| Beta 3 adrenergic agonists App 20050080110 - Sall, Daniel Jon ; et al. | 2005-04-14 |
| Benzofuran derivatives Grant 6,844,344 - He , et al. January 18, 2 | 2005-01-18 |
| Tropane linked benzofuran derivatives Grant 6,835,733 - He , et al. December 28, 2 | 2004-12-28 |
| 3-substituted oxindole beta-3 agonists App 20040242668 - Sall, Daniel Jon ; et al. | 2004-12-02 |
| Piperidines derivatives and their use as serotonin receptor antagonists Grant 6,784,180 - He , et al. August 31, 2 | 2004-08-31 |
| Indole derivatives for the treatment of depression and anxiety App 20040006229 - Hansen, Marvin Martin ; et al. | 2004-01-08 |
| Benzofuran derivatives App 20030232833 - He, John Xiaoqiang ; et al. | 2003-12-18 |
| Piperidines derivatives and their use as serotonin receptor antagonists App 20030225281 - He, John Xiaoqiang ; et al. | 2003-12-04 |
| Benzofuran derivatives App 20030130513 - He, John Xiaoqiang ; et al. | 2003-07-10 |
| Peptidyl calcium channel blockers Grant 6,423,689 - Booth , et al. July 23, 2 | 2002-07-23 |
| Methods of using endothelin antagonists Grant 5,641,752 - Cody , et al. June 24, 1 | 1997-06-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 